Director/PDMR Shareholding
OptiBiotix Health plc announced that David Blain, a Director, purchased 158,965 ordinary shares at 6.17 pence per share on May 28, 2026, increasing his resultant interest to 243,018 shares, representing 0.24% of the issued ordinary shares. This transaction, conducted on the London Alternative Market (AIMX), signifies a direct investment by a company insider.
Select text to share a quote on X · sign in to keep highlights & notes in your OPTI notes
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing products which reduce hunger and food cravings, enhance the gut microbiome, and sweet fibres as healthy sugar substitute, announces that the Company has been informed that David Blain, a Director of the Company, made the following purchase of ordinary shares in the capital of the Company.
Further details are set out in the Notification of Dealing Form below.
| Director | Purchase price | Ordinary shares purchased | Resultant interest in ordinary shares | Resultant percentage of issued ordinary shares |
| David Blain | 6.17 pence | 158,965 | 243,018 | 0.24% |
| a. | Name | David Blain | ||
| 2 | Reason for notification | |||
| a. | Position/Status | Finance Director | ||
| b. | Initial notification/ Amendment | Initial Notification | ||
| a. | Name | OptiBiotix Health Plc | ||
| b. | LEI | 213800UKYQFT941QHS14 | ||
| a. | Description of the financial instrument, type of instrument Identification Code | Ordinary shares of 2p each ISIN: GB00BP0RTP38 | ||
| b. | Nature of the transaction | Purchase of ordinary shares | ||
| c. | Price(s) and volume(s) | |||
| Price(s) per share | Volume(s) | |||
| 6.17 pence | 158,965 | |||
| d. | Aggregated information - Volume - Price | See above | ||
| f. | Place of the transaction | London Alternative Market (AIMX) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.